Chiron Inks $62.5 Mil. Avian Flu Vaccine Deal With HHS
This article was originally published in The Pink Sheet Daily
Executive Summary
HHS Secretary Leavitt looks to cell culture-based technology for more rapid vaccine production in case of future pandemics.